KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Current Taxes: 2013-2015

  • Teva Pharmaceutical Industries' Current Taxes was N/A to $38.7 million in Q3 2015 from the same period last year, while for Sep 2015 it was $38.7 million, marking a year-over-year change of. This contributed to the annual value of $16.6 million for FY2014, which is 22.96% up from last year.
  • Teva Pharmaceutical Industries' Current Taxes amounted to $38.7 million in Q3 2015, which was up 133.13% from $16.6 million recorded in Q4 2014.
  • In the past 5 years, Teva Pharmaceutical Industries' Current Taxes ranged from a high of $38.7 million in Q3 2015 and a low of $13.5 million during Q4 2013.
  • Its 3-year average for Current Taxes is $22.9 million, with a median of $16.6 million in 2014.
  • Data for Teva Pharmaceutical Industries' Current Taxes shows a peak YoY rose of 22.96% (in 2014) over the last 5 years.
  • Over the past 3 years, Teva Pharmaceutical Industries' Current Taxes (Quarterly) stood at $13.5 million in 2013, then increased by 22.96% to $16.6 million in 2014, then reached $38.7 million in 2015.
  • Its last three reported values are $38.7 million in Q3 2015, $16.6 million for Q4 2014, and $13.5 million during Q4 2013.